Yanfang Guan Selected Research

Myeloid-Lymphoid Leukemia Protein

2/2021

DNA damage response as a prognostic indicator in metastatic breast cancer via mutational analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yanfang Guan Research Topics

Disease

38	Neoplasms (Cancer) 01/2022 - 06/2013
12	Breast Neoplasms (Breast Cancer) 01/2022 - 10/2016
6	Lung Neoplasms (Lung Cancer) 12/2021 - 01/2019
5	Hepatocellular Carcinoma (Hepatoma) 04/2020 - 01/2016
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 01/2019
3	Stomach Neoplasms (Stomach Cancer) 11/2020 - 05/2019
3	Liver Neoplasms (Liver Cancer) 10/2020 - 08/2015
3	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2020 - 01/2018
3	Colorectal Neoplasms (Colorectal Cancer) 01/2019 - 01/2016
2	Triple Negative Breast Neoplasms 02/2021 - 12/2020
2	Neoplasm Metastasis (Metastasis) 12/2020 - 01/2019
2	Carcinogenesis 01/2016 - 01/2011
1	Exanthema (Rash) 01/2022
1	Fever (Fevers) 01/2022
1	T-Cell Lymphoma (Lymphoma, T Cell) 10/2021
1	Ovarian Epithelial Carcinoma 01/2021
1	Leukemia 04/2020
1	Lymphatic Metastasis 03/2020
1	Adenocarcinoma of Lung 01/2020
1	Hypoxia (Hypoxemia) 01/2020
1	Carcinoma (Carcinomatosis) 01/2020
1	Heart Diseases (Heart Disease) 01/2020
1	Thrombosis (Thrombus) 01/2020
1	Liver Diseases (Liver Disease) 01/2018
1	von Hippel-Lindau Disease (von Hippel Lindau Disease) 01/2018
1	Hepatitis B 01/2018
1	Hepatitis 01/2018
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2018
1	Hemangioblastoma 01/2018
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2018
1	Chronic Hepatitis B 01/2018
1	Pheochromocytoma 01/2018
1	Prostatic Neoplasms (Prostate Cancer) 01/2018
1	Cushing Syndrome 12/2017
1	Osteoporosis 12/2017
1	Pancreatic Neoplasms (Pancreatic Cancer) 09/2017
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2017
1	Myofibromatosis 06/2013
1	Myofibroma 06/2013

Drug/Important Bio-Agent (IBA)

24	Circulating Tumor DNAIBA 01/2022 - 01/2016
15	DNA (Deoxyribonucleic Acid)IBA 11/2021 - 06/2013
12	Biomarkers (Surrogate Marker)IBA 12/2021 - 08/2015
4	human ERBB2 proteinIBA 01/2022 - 05/2019
4	Immune Checkpoint InhibitorsIBA 01/2021 - 01/2020
3	Proteins (Proteins, Gene)FDA Link 02/2021 - 01/2020
3	Indicators and Reagents (Reagents)IBA 02/2021 - 01/2016
3	RNA (Ribonucleic Acid)IBA 01/2021 - 06/2013
3	Cell-Free Nucleic AcidsIBA 03/2020 - 01/2017
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 10/2021 - 01/2020
2	Hormones (Hormone)IBA 02/2021 - 01/2019
2	ErbB Receptors (EGF Receptor)IBA 02/2021 - 01/2019
2	Complementarity Determining Regions (Complementarity Determining Region)IBA 01/2021 - 01/2020
2	pyrotinibIBA 01/2020 - 01/2020
2	osimertinibIBA 10/2019 - 01/2019
2	Tyrosine Kinase InhibitorsIBA 01/2018 - 10/2016
1	nasIBA 01/2022
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 02/2021
1	Myeloid-Lymphoid Leukemia ProteinIBA 02/2021
1	TensinsIBA 02/2021
1	Carrier Proteins (Binding Protein)IBA 02/2021
1	Cadherins (E-Cadherin)IBA 02/2021
1	Estrogen Receptor alphaIBA 02/2021
1	MAP Kinase Kinase Kinase 1IBA 02/2021
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 02/2021
1	hydrogen sulfite (bisulfite)IBA 01/2021
1	LigandsIBA 01/2021
1	PlatinumIBA 01/2021
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 10/2020
1	Phosphotransferases (Kinase)IBA 10/2020
1	Pharmaceutical PreparationsIBA 10/2020
1	B7-H1 AntigenIBA 06/2020
1	Nuclear Receptor Co-Repressor 1IBA 04/2020
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 03/2020
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2020
1	Biological ProductsIBA 01/2020
1	Fibrinogen (Factor I)FDA Link 01/2020
1	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 01/2020
1	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2020
1	Estrogen ReceptorsIBA 01/2020
1	Messenger RNA (mRNA)IBA 01/2020
1	Cyclin D1IBA 01/2020
1	TOR Serine-Threonine KinasesIBA 01/2020
1	Trastuzumab (Herceptin)FDA Link 05/2019
1	Hepatitis B e AntigensIBA 01/2018
1	AndrogensIBA 01/2018
1	Sunitinib (Sutent)FDA Link 01/2018
1	Nonsense Codon (Nonsense Mutation)IBA 12/2017
1	EpitopesIBA 01/2017
1	CA-19-9 Antigen (CA 19-9 Antigen)IBA 01/2016
1	Carcinoembryonic AntigenIBA 01/2016
1	AntigensIBA 08/2015
1	Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA 06/2013

Therapy/Procedure

16	Therapeutics 01/2022 - 10/2016
7	Immunotherapy 01/2021 - 01/2017
2	Neoadjuvant Therapy 08/2021 - 01/2020
2	Drug Therapy (Chemotherapy) 01/2021 - 09/2017
1	Cytoreduction Surgical Procedures 01/2021
1	Lasers (Laser) 01/2021
1	Radiotherapy 01/2018
1	Adrenalectomy 12/2017